Abstract
The agent of human granulocytic ehrlichiosis (HGE) is a newly recognized tick-borne pathogen that resides within polymorphonuclear leukocytes. C3H/HeN mice can become infected with the agent of HGE (designated aoHGE) by syringe inoculation or tick-borne infection and develop transient neutropenia. They thereby partially mimic human disease and provide a model in which to study immunity to this microorganism. Mice vaccinated with lysates of purified aoHGE, or administered aoHGE antisera, were partially protected from both syringe- and tick-transmitted challenge with aoHGE. These data suggest that antibodies are sufficient to provide substantial, but not complete, immunity against aoHGE.
Original language | English (US) |
---|---|
Pages (from-to) | 3014-3018 |
Number of pages | 5 |
Journal | Journal of Clinical Investigation |
Volume | 100 |
Issue number | 12 |
DOIs | |
State | Published - Dec 15 1997 |
Externally published | Yes |
Keywords
- Antibody
- Ehrlichia
- Intracellular pathogen
- Ticks
- Vaccine